Rate My Professor Mohammadreza Mohebbi

Mohebbi's scholarly output includes over 200 publications, with significant citation impact exceeding 4,000 according to academic profiles. Key publications feature "Psychotropic medication use and bone loss in men: longitudinal study" (2026, co-authored with Weerasinghe, Hodge, Samarasinghe, and Williams), "Depressive Symptoms and Gut Microbiota after Bowel Preparation and Colonoscopy: A Pre-post Intervention Study" (2024, McGuinness et al.), "Modifiable Lifestyle Factors and Cognitive Function: A Population-Based Study Amongst Nondemented Men" (2024, Corney et al.), "The Dietary Inflammatory Index Is Associated with Low Muscle Strength among Men: A Population-Based Study" (2021, Gojanovic et al.), "Physical multimorbidity, depression, and mortality" (2019, International Journal of Geriatric Psychiatry, Mohebbi et al.), and the protocol for "An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression: the TIDE trial" (2024). These works address critical intersections of diet, medication, lifestyle factors, and mental health outcomes, particularly in older adults and clinical cohorts, enhancing methodological standards in health research.